NCT05148832

Administration of Systemic Corticosteroids and the Recovery of Gustatory Functions in Patients With COVID-19

Association Between Administration of Systemic Corticosteroids and the Recovery of Olfactory and/or Gustatory Functions in Patients With COVID-19: A Prospective Cohort Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Fayoum University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Coronavirus is a global pandemic with a high mortality rate; it is started in china in 2019 and rapidly spread worldwide, reaching its epidemic peak in March 2020 Coronavirus is a family of viruses that usually affect animals. They also can affect the respiratory system of humans, causing different manifestations such as difficulty in breathing, coughing, fever, invasive lung lesions, and viral pneumonia

Detailed description

Coronavirus is a global pandemic with a high mortality rate; it is started in china in 2019 and rapidly spread worldwide, reaching its epidemic peak in March 2020 Coronavirus is a family of viruses that usually affect animals. They also can affect the respiratory system of humans, causing different manifestations such as difficulty in breathing, coughing, fever, invasive lung lesions, and viral pneumonia Smell and taste dysfunction is more frequent in the initial stages of covid-19 infection that occur within the first five days and may be used as pivotal symptoms in the early diagnosis of the disease

Conditions

• COVID-19
• Olfactory Dysfunction

Interventions

Type	Name	Description
DRUG	Administration of Systemic Corticosteroid	10 mg of systemic corticosteroids were prescribed weekly to patients to observe taste and smell sensation recovery.

Timeline

• Start date: 2021-05-01
• Primary completion: 2021-08-20
• Completion: 2021-11-15
• First posted: 2021-12-08
• Last updated: 2021-12-22

Locations

1 site across 1 country: Egypt